TransCode Therapeutics In... (RNAZ)
undefined
undefined%
At close: undefined
3.64
-1.89%
After-hours Jan 03, 2025, 04:00 PM EST

TransCode Therapeutics Inc. Forecast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for RNAZ stock have an median target of 20, with a low estimate of 20 and a high estimate of 20. The median target predicts an increase of 439.08% from the current stock price of 3.71.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $20 $20 $20 $20
Change 439.08% 439.08% 439.08% 439.08%

AI Analyst Report

HC Wainwright & Co. has reiterated a Buy rating fo... Unlock content with Pro Subscription

Updated Dec 18, 2024

Rating May 24Aug 24Sep 24Oct 24Nov 24Dec 24
Strong Buy 000001
Buy 211110
Hold 000000
Sell 000000
Strong Sell 000000
Total 2 1 1 1 1 1

Financial Forecast this Year

Revenue This Year
1.00M
from -
Increased by ∞B%
Revenue Next Year
500.00K
from 1.00M
Increased by -50%
EPS This Year
-0.6
from null
Increased by -∞B%
EPS Next Year
-0.36
from -0.6
Increased by 40.0%